WAVE LIFE SCIENCES LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.455 USD | +1.18% |
|
+10.96% | +28.32% |
| May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
| May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
Presenter SpeechKaey Nakae (Analysts)It's my pleasure to introduce our next guest from Wave Li...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Wave Life Sciences Ltd. is a biotechnology company. The Company is focused on unlocking the potential of RNA medicines (oligonucleotides), or those targeting ribonucleic acid (RNA), to transform human health. Its RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing and RNA interference (RNAi), providing Company with capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntingtonâs disease, as well as a preclinical program in obesity. These programs include WVE-N531, WVE-006 and WVE-003. It is also building a pipeline of novel A-to-I RNA editing oligonucleotides (AIMers).
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
6.38
USD
Average target price
12.86
USD
Spread / Average Target
+101.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +28.32% | 781M | |
| +9.56% | 115B | |
| +13.29% | 107B | |
| -13.58% | 22.31B | |
| -3.61% | 21.6B | |
| -5.71% | 18.23B | |
| -38.57% | 17.62B | |
| +7.78% | 14.26B | |
| +34.44% | 12.37B | |
| -26.99% | 8.28B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Transcript : Wave Life Sciences Ltd. Presents at Chardan’s 6th Annual Genetic Medicines and Cell Therapy Conference, Apr-26-2022 02